ArticleDiscover nano2026
Synthesis and biological assessment of silver nanoparticles using Adiantum incisum extracts.
Article in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Silver nanoparticles (Ag NPs) were synthesized using methanolic and ethanolic extracts of Adiantum incisum and evaluated different biological activities. The synthesis of Ag NPs was confirmed by color change and UV-vis spectroscopy absorption peak at 400-500 nm. Furthermore, optimized biosynthesis by adjusting parameters such as temperature (50-65 °C for methanolic extract and 35 °C for ethanolic extract), pH (Optimum pH 9-10), and various salt concentrations (0.2 mL NaCl showed maximum stability). Additionally, the characterization of silver nanoparticles was performed using Fourier-transform infrared spectroscopy (FTIR) which revealed the presence of functional groups involved in capping and reduction, X-ray diffraction (XRD) which confirmed the face-centered cubic crystalline structure, energy dispersive X-ray spectroscopy (EDX) confirmed the presence of elemental silver, and scanning electron microscopy (SEM) revealed monodispersed spherical particles. Similarly, the biological activities of plant extracts and synthesized silver nanoparticles were evaluated. Insecticidal assays against Tribolium castaneum showed 56.7% and 53.4% mortality for methanolic and ethanolic Ag NPs at 1000 µg/mL. Phytotoxicity tests against Lemna minor indicated 51.11% inhibition for ethanolic-extract synthesized Ag NPs, while 45.5% inhibition for methanolic-extract synthesized Ag NPs. Antioxidant activity assessed using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay revealed 85.2% inhibition for ethanolic Ag NPs and 64.96% inhibition for methanolic Ag NPs at 500 µg/mL. The analgesic potential was evaluated using the acetic acid-induced writhing test, where ethanolic silver nanoparticles demonstrated 65.2% inhibition and methanolic silver nanoparticles 61.11% inhibition at 500 µg/mL. The anti-inflammatory activity showed 79.2% inhibition for methanolic Ag NPs and 75% inhibition for ethanolic Ag NPs at 300 µg/mL. Antibacterial assays against Shigella dysenteriae and Pseudomonas aureginosa showed inhibition zone of 22 mm against S. dysenteriae and 20 mm against P. aureginosa for ethanolic Ag NPs and 22 mm against S. dysenteriae and 18 mm against P. aureginosa for methanolic Ag NPs. Antifungal activity against Aspergillus niger also showed a notable inhibition zone, where methanolic silver nanoparticles showed 14 mm and ethanolic silver nanoparticles showed 12 mm inhibition at 100 µg/mL. Furthermore, some parameters such as particle size or surface charge are the shortcomings of the study. These findings demonstrate that the biosynthesis of silver nanoparticles from A. incisum extracts exhibits significant biological activities, highlighting their potential applications in pharmaceutical and agricultural fields.
Indexed as
Identifiers
42911456What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.